Idiopathic Thrombocytopenia Purpura Therapeutics Market to Reach...

added blog Health

2025-09-08 15:11:17 -

Idiopathic Thrombocytopenia Purpura Therapeutics Market to Reach USD 1,122 Million by 2035

The global idiopathic thrombocytopenia purpura (ITP) therapeutics market is poised for significant growth, with its valuation projected to increase from USD 661 million in 2024 to USD 1,122 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2035. This expansion is driven by the increasing prevalence of ITP, advancements in targeted therapies, and rising demand...

0 Comments 0 Shares 58 Views